SHPMF vs SHPMY
To understand the difference between Shanghai Pharmaceuticals Holding Co. Ltd. - Ordinary Shares - Class H (SHPMF) vs. Shanghai Pharmaceuticals Holding Co. Ltd. - ADR (SHPMY) it is enough to know the definitions of Ordinary Shares - Class H and ADR
Ordinary Shares - Class H - The Chinese stock markets have strict restrictions on who can buy and what is available to investors for purchase. Chinese H-shares represent the shares of publicly-traded incorporated Chinese companies listed on the Hong Kong Stock Exchange and trade with a face value of Hong Kong dollars (HKD). Before 2007, H-shares were provided only for foreign investors. Since foreign investors trade H-shares, they have become more liquid in comparison to A-shares which represent publicly listed Chinese companies that trade on the Shenzhen and Shanghai Stock Exchanges in yuan renminbi (CNY). Thus, this resulted in A-shares being traded at a premium to H-shares of a similar company.
ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
SHPMF’s FA Score shows that 0 FA rating(s) are green whileSHPMY’s FA Score has 0 green FA rating(s).
- SHPMF’s FA Score: 0 green, 5 red.
- SHPMY’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
SHPMF’s TA Score shows that 2 TA indicator(s) are bullish while SHPMY’s TA Score has 1 bullish TA indicator(s).
- SHPMF’s TA Score: 2 bullish, 2 bearish.
- SHPMY’s TA Score: 1 bullish, 5 bearish.
Price Growth
SHPMF (@Medical Distributors) experienced а +1.29% price change this week, while SHPMY (@Medical Distributors) price change was -1.27% for the same time period.
The average weekly price growth across all stocks in the @Medical Distributors industry was +1.14%. For the same industry, the average monthly price growth was +1.42%, and the average quarterly price growth was +4.17%.
Industries' Descriptions
@Medical Distributors (+1.14% weekly)Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
| SHPMF | SHPMY | SHPMF / SHPMY | |
| Capitalization | 9.5B | 9.5B | 100% |
| EBITDA | 11.1B | 11.1B | 100% |
| Gain YTD | -4.268 | -6.419 | 66% |
| P/E Ratio | 8.28 | 8.39 | 99% |
| Revenue | 241B | 241B | 100% |
| Total Cash | 38.1B | N/A | - |
| Total Debt | 44.4B | N/A | - |
SHPMF | SHPMY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 95 | 54 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 38 Fair valued | 37 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 81 | 81 | |
PRICE GROWTH RATING 1..100 | 44 | 51 | |
P/E GROWTH RATING 1..100 | 57 | 41 | |
SEASONALITY SCORE 1..100 | 30 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SHPMY's Valuation (37) in the null industry is in the same range as SHPMF (38). This means that SHPMY’s stock grew similarly to SHPMF’s over the last 12 months.
SHPMY's Profit vs Risk Rating (100) in the null industry is in the same range as SHPMF (100). This means that SHPMY’s stock grew similarly to SHPMF’s over the last 12 months.
SHPMY's SMR Rating (81) in the null industry is in the same range as SHPMF (81). This means that SHPMY’s stock grew similarly to SHPMF’s over the last 12 months.
SHPMF's Price Growth Rating (44) in the null industry is in the same range as SHPMY (51). This means that SHPMF’s stock grew similarly to SHPMY’s over the last 12 months.
SHPMY's P/E Growth Rating (41) in the null industry is in the same range as SHPMF (57). This means that SHPMY’s stock grew similarly to SHPMF’s over the last 12 months.
| SHPMF | SHPMY | |
|---|---|---|
| RSI ODDS (%) | 15 days ago 54% | N/A |
| Stochastic ODDS (%) | 15 days ago 63% | 15 days ago 67% |
| Momentum ODDS (%) | 15 days ago 59% | 15 days ago 61% |
| MACD ODDS (%) | N/A | 15 days ago 67% |
| TrendWeek ODDS (%) | 15 days ago 51% | 15 days ago 62% |
| TrendMonth ODDS (%) | 15 days ago 40% | 15 days ago 67% |
| Advances ODDS (%) | N/A | N/A |
| Declines ODDS (%) | N/A | 17 days ago 61% |
| BollingerBands ODDS (%) | N/A | N/A |
| Aroon ODDS (%) | N/A | 15 days ago 73% |
SHPMF and
Correlation & Price change
A.I.dvisor tells us that SHPMF and ARRJF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHPMF and ARRJF's prices will move in lockstep.
| Ticker / NAME | Correlation To SHPMF | 1D Price Change % | ||
|---|---|---|---|---|
| SHPMF | 100% | N/A | ||
| ARRJF - SHPMF | 8% Poorly correlated | N/A | ||
| SHPMY - SHPMF | 7% Poorly correlated | N/A | ||
| ZYXI - SHPMF | 5% Poorly correlated | +5.99% | ||
| COSM - SHPMF | 2% Poorly correlated | +8.47% | ||
| MAHLY - SHPMF | 2% Poorly correlated | +2.99% | ||
More | ||||
SHPMY and
Correlation & Price change
A.I.dvisor tells us that SHPMY and NSVGF have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHPMY and NSVGF's prices will move in lockstep.
| Ticker / NAME | Correlation To SHPMY | 1D Price Change % | ||
|---|---|---|---|---|
| SHPMY | 100% | N/A | ||
| NSVGF - SHPMY | 14% Poorly correlated | N/A | ||
| COSM - SHPMY | 12% Poorly correlated | +8.47% | ||
| SHTDF - SHPMY | 12% Poorly correlated | N/A | ||
| ZYXI - SHPMY | 7% Poorly correlated | +5.99% | ||
| SHPMF - SHPMY | 7% Poorly correlated | N/A | ||
More | ||||